Status:
COMPLETED
Topical Mebo Versus Lidocane in Healing Time of Traumatic Oral Ulcer
Lead Sponsor:
October 6 University
Conditions:
Mebo
Lidocaine
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
This study aims to assess topical MEBO application on pain relief and wound healing.
Detailed Description
One of the conditions that affect the mouth frequently is a traumatic ulcer. Between 3 and 24 % of the population are affected, which is a significant prevalence. It is symptomatic to treat traumatize...
Eligibility Criteria
Inclusion
- Age from 20 to 50 years.
- Both sexes.
- Systemically healthy patients.
- Patients with good oral hygiene.
Exclusion
- Patients with any uncontrolled local or systemic disease.
- Smokers.
- Pregnancy and lactation.
- Patients allergic to the used agents.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06184282
Start Date
July 1 2023
End Date
August 1 2023
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
October 6 University
Giza, Egypt, 12511